Evolving Principles of Surgical Management and Prognostic Factors for Outcome in Renal Cell Carcinoma
Authors:
- 10 December 2006
- journal article
- review article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 24 (35) , 5565-5575
Abstract
The generally accepted principles for the surgical management of renal cell carcinoma (RCC) were first described more than 30 years ago. Since then, much has changed in the understanding of the basic biology and genetics of kidney cancer. Improvements in cross-sectional imaging has allowed for more accurate preoperative clinical staging of renal tumors, and the necessity of completing all the components of the radical nephrectomy have been questioned. Surgical techniques have also evolved, and technology has advanced to make possible new methods of managing renal tumors. The TNM staging system is currently the most extensively used system to provide prognostic information for RCC. However, data published in the last few years has led to significant controversies as to whether further revisions are needed and whether improvements can be made with the introduction of new, more accurate and predictive prognostic factors. Furthermore, the recent discovery of molecular tumor markers are expected to revolutionize the staging of RCC and lead to the development of new therapies based on molecular targeting. This review will examine the evolving principles in the surgical management of RCC as well as provide an update on current staging modalities and prognostic factors.Keywords
This publication has 179 references indexed in Scilit:
- Editorial commentJournal of Urology, 2006
- Scoring algorithm to predict survival after nephrectomy and immunotherapy in patients with metastatic renal cell carcinomaCancer, 2003
- Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinomaCancer, 2003
- Recent advances in insulin gene therapy for type 1 diabetesTrends in Molecular Medicine, 2002
- Hypoxia — a key regulatory factor in tumour growthNature Reviews Cancer, 2002
- Regional lymph node dissection in the treatment of renal cell carcinoma: is it useful in patients with no suspected adenopathy before or during surgery?BJU International, 2001
- REEVALUATION OF THE 1997 TNM CLASSIFICATION FOR RENAL CELL CARCINOMA: T1 AND T2 CUTOFF POINT AT 4.5 RATHER THAN 7 CM. BETTER CORRELATES WITH CLINICAL OUTCOMEJournal of Urology, 2001
- Disease Outcome in Patients With Low Stage Renal Cell Carcinoma Treated With Nephron Sparing or Radical SurgeryJournal of Urology, 1996
- Prognostic Factors for Survival in Patients with Metastatic Renal Cancer Treated with Biological Response ModifiersJournal of Urology, 1995
- Original Articles: Kidney Cancer: Renal Cell Carcinoma: Tumor Size, Stage and SurvivalJournal of Urology, 1995